Post-effective amendment to a registration statement that is not immediately effective upon filing

Consolidated Statement of Shareholders' Equity (Deficit)

v3.22.1
Consolidated Statement of Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Series P2 Convertible Preferred Stock [Member]
Previously Reported [Member]
Preferred Stock [Member]
Convertible Preferred Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Preferred Stock [Member]
Previously Reported [Member]
Convertible Preferred Stock [Member]
Common Stock [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Common Stock [Member]
Series P2 Convertible Preferred Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid in Capital [Member]
Additional Paid in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid in Capital [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Additional Paid in Capital [Member]
Series P2 Convertible Preferred Stock [Member]
Additional Paid in Capital [Member]
Previously Reported [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Cumulative Effect, Period of Adoption, Adjusted Balance [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Beginning balance at Dec. 31, 2019   $ 129,921 $ 2,978   $ (126,943) $ (129,921) $ 129,921   $ (53) $ 6   $ 59   $ 129,974 $ 170,600   $ 40,626   $ (167,628) $ (167,628)
Beginning balance, Shares at Dec. 31, 2019           (153,758,348) 153,758,348   (1,992,064) 63,204,426   65,196,490                
Issuance of common stock upon exercise of stock options $ 66             $ 1         $ 65              
Issuance of common stock upon exercise of stock options, Shares 5,318,139             5,318,139                        
Vesting of early exercised stock options $ 21                       21              
Issuance of series P-2 Preferred stock Number of shares issued                     27,989,240                  
Issuance of Series P-2 convertible preferred stock       $ 63,932             $ 3         $ 63,929        
Repurchase of unvested restricted common stock, Shares               (3,230)                        
Conversion of promissory notes to Series P-2 convertible preferred stock       $ 8,203                       $ 8,203        
Conversion of promissory notes to Series P-2 convertible preferred stock, Shares                     3,507,984                  
Stock-based compensation 666                       666              
Net income (loss) (39,650)                                 $ (39,650)    
Ending balance at Dec. 31, 2020 $ 36,216   36,216         $ 10   $ 10     243,484   243,484     (207,278) (207,278)  
Ending balance, Shares at Dec. 31, 2020 100,016,559             100,016,559   100,016,559                    
Issuance of common stock upon exercise of stock options $ 30                       30              
Issuance of common stock upon exercise of stock options, Shares               2,112,373                        
Vesting of early exercised stock options 24                       24              
Repurchase of unvested restricted common stock, Shares               (87,768)                        
Issuance of Series D convertible preferred stock upon exercise of warrants 20,877                       20,877              
Issuance of Series D convertible preferred stock upon exercise of warrants, Shares               2,020,034                        
Stock-based compensation 1,555                       1,555              
Net income (loss) (16,165)                                 (16,165)    
Ending balance at Mar. 31, 2021 42,537             $ 10         265,970         (223,443)    
Ending balance, Shares at Mar. 31, 2021               104,061,198                        
Beginning balance at Dec. 31, 2020 $ 36,216   $ 36,216         $ 10   $ 10     243,484   $ 243,484     (207,278) $ (207,278)  
Beginning balance, Shares at Dec. 31, 2020 100,016,559             100,016,559   100,016,559                    
Issuance of common stock upon exercise of stock options $ 62                       62              
Issuance of common stock upon exercise of stock options, Shares 2,180,168             2,180,168                        
Vesting of early exercised stock options $ 111                       111              
Repurchase of unvested restricted common stock, Shares               (433,359)                        
Issuance of Series D convertible preferred stock upon exercise of warrants 20,877                       20,877              
Issuance of Series D convertible preferred stock upon exercise of warrants, Shares               2,020,034                        
Business combination, net of redemptions and equity issuance costs and PIPE financing, net 300,745             $ 4         300,741              
Business combination, net of redemptions and equity issuance costs and PIPE financing, net, Shares               41,249,985                        
Issuance of common stock upon exercise of common stock warrants, value 82,546             $ 1         82,545              
Issuance of common stock upon exercise of common stock warrants, shares               7,177,885                        
Vesting of restricted stock units               61,015                        
Stock-based compensation 11,434                       11,434              
Net income (loss) (125,874)                                 (125,874)    
Ending balance at Jan. 02, 2022 $ 326,117             $ 15         659,254         (333,152)    
Ending balance, Shares at Jan. 02, 2022 152,272,287             152,272,287                        
Issuance of common stock upon exercise of stock options $ 200                       200              
Issuance of common stock upon exercise of stock options, Shares 91,910             91,910                        
Vesting of early exercised stock options $ 42                       42              
Repurchase of unvested restricted common stock, Shares               (105,886)                        
Issuance of common stock upon exercise of common stock warrants, value 47,452                       47,452              
Issuance of common stock upon exercise of common stock warrants, shares               4,126,466                        
Vesting of restricted stock units               34,941                        
Stock-based compensation 4,536                       4,536              
Net income (loss) 42,707                                 42,707    
Ending balance at Apr. 03, 2022 $ 421,054             $ 15         $ 711,484         $ (290,445)    
Ending balance, Shares at Apr. 03, 2022 156,419,718             156,419,718